Shawn Barman

发表

Broadening a SARS-CoV-1 neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution

D. Burton, I. Wilson, B. Briney, 2021, bioRxiv.

One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

Paul J. Steiner, Timothy A. Whitehead, J. Jardine, 2021, Cell Reports.

Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus

D. Burton, D. Watkins, R. Desrosiers, 2021, Nature Communications.

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways

Timothy A. Whitehead, D. Burton, D. Nemazee, 2022, bioRxiv.

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

D. Burton, I. Wilson, N. Wu, 2021, Cell Host & Microbe.

One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

Paul J. Steiner, Timothy A. Whitehead, J. Jardine, 2021, bioRxiv.

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

S. Bhattacharyya, A. Awasthi, J. Torres, 2021, bioRxiv.

Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies

D. Burton, B. Briney, Collin Joyce, 2023, PLoS pathogens.

Engineering SARS-CoV-2 neutralizing antibodies for increased 1 potency and reduced viral escape 2 AUTHORS

Timothy A. Whitehead, D. Burton, D. Nemazee, 2022 .

Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins

D. Burton, Po-Ssu Huang, H. Turner, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution

D. Burton, Collin Joyce, D. Nemazee, 2023, Science Signaling.